Nicholas P. Grund

Nicholas P. Grund

Senior Vice President, Chief Commercial OfficeratAkebia Therapeutics· In proxies 2024–2025

Pay in FY2025-7% from the year before · Akebia Therapeutics stock -15.3% the same year

Nicholas P. Grund was paid $1.7M in FY2025 (Dec), down 7%. Akebia Therapeutics stock fell 15.3% that year.

Pay$100 in the stock at the end of FY23 → $130
Pay is from the Summary Compensation Table of each Akebia Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Akebia TherapeuticsPublic company · 2 yr
    • Senior Vice President, Chief Commercial Officer2024 – Present · 2 yrStock in role -36%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?